A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.

导出 OA

翻译打印收藏纠错

作者： Gergely,Krivan ^[1] ; Ludmila,Chernyshova ^[2] ; Larysa,Kostyuchenko ^[3] ; Andrzej,Lange ^[4] ; Zoltan,Nyul ^[5] ; Beata,Derfalvi ^[6] ; Jacek,Musial ^[7] ; Anne,Bellon ^[8] ; Martin,Kappler ^[9] ; Alain,Sadoun ^[10] ; Ewa,Bernatowska ^[11]

作者单位： Paediatric Haematology and Stem Cell Transplantation Department, Szent Laszlo Hospital, Budapest, Hungary. ^[1] Department of Paediatric Infectious Diseases and Clinical Immunology, P.L. Shupyk National Medical Academy for Post-graduate Education, Kiev, Ukraine. ^[2] West Ukrainian Specialized Children's Medical Centre, Lviv, Ukraine. ^[3] Lower Silesian Center for Cellular Transplantation/Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland. ^[4] Children's Department, University of Pécs, Pécs, Hungary. ^[5] 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary. ^[6] Alergiczno Internistyczny All-Med Specjalistyczny Osrodek, Krakow, Poland. ^[7] Clinical Development Department, LFB Biotechnologies, BP 40305, 3 avenue des Tropiques, Les Ulis, 91958, Courtaboeuf Cedex, France. ^[8] Statalpha, Baziège, France. ^[9] Clinical Development Department, LFB Biotechnologies, BP 40305, 3 avenue des Tropiques, Les Ulis, 91958, Courtaboeuf Cedex, France. sadoun@lfb.fr. ^[10] Immunology Clinic Department, Children's Memorial Health Institute, Warsaw, Poland. ^[11]

关键词 Clinical trials IVIg Immunoglobulins